PARDEEP KAUR: Open Payments
NPI 1225783855 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 22 payments from 9 companies in 2025. Trend: 2023 $314 · 2024 $348 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 11 | $147 |
| Boston Scientific Corporation | 3 | $113 |
| Novartis Pharmaceuticals Corporation | 2 | $31 |
| Actelion Pharmaceuticals US, Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $26 |
| ConvaTec Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Ionis Pharmaceuticals, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $14 |
Products named: LINQ II, General - Therapies, ACCOLADE SR, LEQVIO, OPSYNVI, MOUNJARO, AQUACEL AG+ EXTRA, ELIQUIS.
Industry payments across CA — which companies pay providers there.
